InsidersTradesSigma
Browse the full record of transactions filed by Soparkar Peter, Dirigeant. Director active across 1 companies, notably Adverum Biotechnologies, Inc.. Aggregated, 5 reports have been recorded. Total volume traded: €85k. The latest transaction was disclosed on 19 April 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
5 of 5 declarations
Peter Soparkar is an Executive at Adverum Biotechnologies, Inc. In this role, he participates in the strategic direction of the company. Soparkar brings valuable expertise in the sector, thereby contributing to informed decision-making and optimizing Adverum's performance. His commitment to operational excellence is an asset for the company.